{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:14:29Z","timestamp":1770297269798,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.sapharm.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:06:51Z","timestamp":1628104011000},"page":"3199-3203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Opioid use disorder: Calling pharmacists to action for better preconception and pregnancy care"],"prefix":"10.1016","volume":"18","author":[{"given":"Julia D.","family":"Muzzy Williamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"DiPietro Mager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin W.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.sapharm.2021.08.004_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5055\/jom.2021.0623","article-title":"Opioid prescription claims among women aged 15-44 years-United States, 2013-2017","volume":"17","author":"Summers","year":"2021","journal-title":"J Opioid Manag"},{"issue":"28","key":"10.1016\/j.sapharm.2021.08.004_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","article-title":"Vital signs: prescription opioid pain reliever use during pregnancy - 34 U.S. jurisdictions, 2019","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.sapharm.2021.08.004_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.sapharm.2021.08.004_bib5","article-title":"Maternal use of opioids during pregnancy and congenital malformation: a systematic review","volume":"139","author":"Lind","year":"2017","journal-title":"An Pediatr"},{"issue":"No. RR-1","key":"10.1016\/j.sapharm.2021.08.004_bib6","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"13","key":"10.1016\/j.sapharm.2021.08.004_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2021.08.004_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007-2016","volume":"136","author":"Jarlenki","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.sapharm.2021.08.004_bib11","first-page":"e81","article-title":"Committee opinion No. 711. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.sapharm.2021.08.004_bib12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/jac5.1331","article-title":"Mobilizing pharmacists to address the opioid crisis: a joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of clinical pharmacy","volume":"3","author":"Coon","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.sapharm.2021.08.004_bib13","first-page":"85","article-title":"Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review","volume":"8","author":"Lindley","year":"2019","journal-title":"Integrated Pharm Res Pract"},{"issue":"22","key":"10.1016\/j.sapharm.2021.08.004_bib15","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.2020.8020","article-title":"Screening for unhealthy drug use: US preventive services Task Force recommendation statement","volume":"323","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"No. RR-6","key":"10.1016\/j.sapharm.2021.08.004_bib16","first-page":"1","article-title":"Recommendations to improve preconception health and health care - United States: a report of the CDC\/ATSDR preconception care work group and the select panel on preconception care","volume":"55","author":"Johnson","year":"2006","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"3","key":"10.1016\/j.sapharm.2021.08.004_bib17","first-page":"1e62","article-title":"Core state preconception health indicators: pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009","volume":"63","author":"Robbins","year":"2014","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.sapharm.2021.08.004_bib18","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1331\/JAPhA.2014.14536","article-title":"The pharmacist's role in promoting preconception health","volume":"54","author":"El-Ibiary","year":"2014","journal-title":"J Am Pharmaceut Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2021.08.004_bib19","first-page":"141","article-title":"Fulfilling an unmet need: roles for clinical pharmacists in preconception care","volume":"36","author":"DiPietro Mager","year":"2016","journal-title":"Pharma"},{"issue":"1","key":"10.1016\/j.sapharm.2021.08.004_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.24926\/iip.v5i1.323","article-title":"Medication therapy management and preconception care: opportunities for pharmacist intervention","volume":"5","author":"DiPietro","year":"2014","journal-title":"Innov Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2021.08.004_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.sapharm.2015.05.011","article-title":"Confronting inequities: a scoping review of the literature on pharmacist practice and health-related disparities","volume":"12","author":"Wenger","year":"2016","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2021.08.004_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.24926\/iip.v7i3.458","article-title":"Pharmacists' provision of contraception: established and emerging roles","volume":"7","author":"Peters","year":"2016","journal-title":"Innov Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2021.08.004_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.sapharm.2021.08.004_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.sapharm.2021.08.004_bib24","series-title":"UpToDate. UpToDate","article-title":"Counseling and selection","author":"Dehlendorf","year":"2020"},{"key":"10.1016\/j.sapharm.2021.08.004_bib27","series-title":"Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.sapharm.2021.08.004_bib28","series-title":"Drugs and Lactation Database (LactMed)","year":"2006"},{"key":"10.1016\/j.sapharm.2021.08.004_bib30","author":"March of Dimes"},{"issue":"RR-04","key":"10.1016\/j.sapharm.2021.08.004_bib31","first-page":"1","article-title":"Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs","volume":"63","author":"Gavin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2021.08.004_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15585\/mmwr.mm6914a3","article-title":"Update to U.S. medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection","volume":"69","author":"Tepper","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.sapharm.2021.08.004_bib33","article-title":"Association of pharmacist prescription with dispensed duration of hormonal contraception","volume":"3","author":"Rodriquez","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2021.08.004_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1331\/JAPhA.2012.11213","article-title":"Current trends in outpatient pharmacy services and billing","volume":"52","author":"Beatty","year":"2012","journal-title":"J Am Pharmaceut Assoc"},{"key":"10.1016\/j.sapharm.2021.08.004_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.japh.2018.11.001","article-title":"A sustainable business model for comprehensive medication management in a patient-centered medical home","volume":"59","author":"Fabel","year":"2019","journal-title":"J Am Pharmaceut Assoc"},{"issue":"12","key":"10.1016\/j.sapharm.2021.08.004_bib36","first-page":"1273","article-title":"Incident-to billing for pharmacists","volume":"24","author":"Dietrich","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"10.1016\/j.sapharm.2021.08.004_bib37","first-page":"824","article-title":"Methadone, buprenorphine, and naltrexone for the treatment of opioid use disorder in pregnant women","volume":"37","author":"Tran","year":"2017","journal-title":"Pharma"},{"issue":"3","key":"10.1016\/j.sapharm.2021.08.004_bib38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.pec.2010.09.002","article-title":"Now is the chance: patient-provider communication about unplanned pregnancy during the first prenatal visit","volume":"81","author":"Meiksin","year":"2010","journal-title":"Patient Educ Counsel"},{"issue":"5","key":"10.1016\/j.sapharm.2021.08.004_bib39","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.ajog.2008.03.049","article-title":"Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy?","volume":"199","author":"Kuroki","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.sapharm.2021.08.004_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.contraception.2005.05.022","article-title":"Postpartum contraception: the New Mexico pregnancy risk assessment monitoring system","volume":"72","author":"Depi\u00f1eres","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.sapharm.2021.08.004_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10995-010-0738-9","article-title":"Is effective contraceptive use conceived prenatally in Florida? The association between prenatal contraceptive counseling and postpartum contraceptive use","volume":"16","author":"Hernandez","year":"2012","journal-title":"Matern Child Health J"},{"issue":"3","key":"10.1016\/j.sapharm.2021.08.004_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jadohealth.2012.05.004","article-title":"Postpartum contraceptive use among adolescent mothers in seven states","volume":"52","author":"Wilson","year":"2013","journal-title":"J Adolesc Health"},{"issue":"15","key":"10.1016\/j.sapharm.2021.08.004_bib43","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.295.15.1809","article-title":"Birth spacing and risk of adverse perinatal outcomes: a meta-analysis","volume":"295","author":"Conde-Agudelo","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2021.08.004_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OAJC.S52925","article-title":"Prenatal contraceptive counseling and method provision after childbirth","volume":"6","author":"Nelson","year":"2015","journal-title":"Open Access J Contracept"},{"issue":"11","key":"10.1016\/j.sapharm.2021.08.004_bib45","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1377\/hlthaff.2020.00106","article-title":"Medicaid expansion increased preconception health counseling, folic acid intake, and postpartum contraception","volume":"39","author":"Myerson","year":"2020","journal-title":"Health Aff"},{"issue":"1","key":"10.1016\/j.sapharm.2021.08.004_bib46","first-page":"31","article-title":"Breastfeeding and health outcomes for the mother-infant dyad","volume":"60","author":"Dieterich","year":"2013","journal-title":"Pediatr Clin"},{"issue":"7","key":"10.1016\/j.sapharm.2021.08.004_bib47","first-page":"861","article-title":"Breastfeeding considerations for mothers of infants with neonatal abstinence syndrome","volume":"37","author":"Holmes","year":"2017","journal-title":"Pharma"},{"issue":"5","key":"10.1016\/j.sapharm.2021.08.004_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/03630242.2013.804025","article-title":"Postpartum substance use and depressive symptoms: a review","volume":"53","author":"Carrol Capman","year":"2013","journal-title":"Women Health"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121002904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121002904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:26:47Z","timestamp":1761557207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741121002904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1551741121002904"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.08.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid use disorder: Calling pharmacists to action for better preconception and pregnancy care","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}